NEWS DETAIL

Orca Bio的细胞疗法Tregzi获得FDA批准，引起轰动。接下来会是IPO吗？

Orca Bio公司凭借其首个用于治疗需要移植的血液癌症患者的基因工程细胞疗法Tregzi，成功进军商业市场。周二，FDA批准了这种基于同种异体调节性T细胞（Treg）的免疫疗法，也称为Orca-T，可作为干细胞移植的替代方案，用于提高成人血液系统恶性肿瘤患者的无慢性移植物抗宿主病（GVHD）生存率。Tregzi的核心是一种经过基因改造的造血干细胞移植（HS…

医药资讯 July 2, 2026

该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

Produk Berkaitan Artikel Ini

Produk ini dipadankan secara automatik berdasarkan tajuk, ringkasan, dan kandungan artikel.

Soalan Lazim

Which products are related to this article?

The system matched these relevant products from the article content: LuciBelu Belumosudil – Beli dalam talian.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.